USA Today (12/13, Walrath-Holdridge) reported the FDA last week recalled “a popular antidepressant, often known by the brand name Cymbalta…due to the presence of a potentially cancer-causing chemical. More than 233,000 bottles of duloxetine capsules sold by Rising Pharmaceuticals were voluntarily recalled on Nov. 19, and the U.S. Food and Drug Administration assigned the recall as a class II risk on Dec. 5. The risk level is the FDA’s second most severe level as it could cause ‘temporary or medically reversible adverse health consequences.’”
Related Links:
— “What is duloxetine and how does it work? What to know about antidepressant recalled by FDA,” Mary Walrath-Holdridge, USA Today, December 13, 2024